文献速递生殖医学

结局相似而时机不同:体外受精中黄体期与卵泡期促排卵的比较

Similar outcomes, different timings: luteal vs. follicular stimulation in in vitro fertilization.
PubMed 文献 · Fertil Steril · 2025-09-02

回顾性队列研究比较黄体期与卵泡期促排卵对胚胎数量、倍性和质量的影响,初始队列含卵泡期3524周期和黄体期552周期,经2:1倾向评分匹配后卵泡期1058周期与黄体期550周期配对。黄体期促排卵所需时间更长且促性腺激素总剂量更高,但获卵数、成熟卵母细胞数、受精卵数、囊胚数、整倍体囊胚数及胚胎质量分布在匹配队列中无显著差异。作者认为黄体期促排卵对倍性和胚胎质量无不利影响,其主要优势是启动促排卵的时间窗口更宽。

要点

  • 黄体期促排卵所需刺激时间中位数11.0天,长于卵泡期的10天,促性腺激素总剂量中位数4050 IU高于3300 IU。
  • 匹配队列多变量回归显示黄体期相对卵泡期的成熟卵母细胞数调整IRR为1.04(95%CI 1.00-1.09)。
  • 配对分析中两组获卵数、成熟卵母细胞数、受精卵数、囊胚数、活检囊胚数及整倍体囊胚数均无统计学显著差异。

核心结论

  • 黄体期启动的卵巢刺激对整倍体胚胎数量和胚胎质量无不利影响。
  • 黄体期刺激的主要优势是启动卵巢刺激的时间窗口更宽,可能对时间受限的夫妇有用。

研究设计与样本

  • 回顾性队列研究,时间范围为2017年3月至2024年11月。
  • 研究对象为在月经周期卵泡期或黄体期启动卵巢刺激的女性。
  • 初始队列包含3524个卵泡期周期和552个黄体期周期。
  • 按年龄、体重指数、抗苗勒管激素、窦卵泡计数、精液来源、所用刺激药物进行2:1倾向评分匹配后,1058个卵泡期周期与550个黄体期周期匹配。
  • 另对147名在一年内分别接受黄体期和卵泡期周期的女性进行配对分析。

主要发现

  • 黄体期刺激所需时间显著更长(中位数11.0天 vs 10天),促性腺激素总剂量显著更高(中位数4050 IU vs 3300 IU)。
  • 回归调整前,两组卵丘-卵母细胞复合体、成熟(MII)卵母细胞、受精卵母细胞、总囊胚、活检囊胚及整倍体囊胚的中位数计数无显著差异。
  • 匹配队列多变量回归显示,黄体期相对卵泡期的MII计数调整IRR为1.04(95%CI 1.00-1.09),囊胚计数调整IRR为1.05(95%CI 0.99-1.11),整倍体囊胚计数调整IRR为1.04(95%CI 0.94-1.14)。
  • 胚胎质量分布无显著差异:卵泡期组(N=3831)顶级8.4%、良好49.5%、一般22.1%、差20.0%;黄体期组(N=2110)顶级9.4%、良好51.1%、一般20.9%、差18.6%。
  • 配对分析中,黄体期周期刺激时间中位数11天 vs 10天,促性腺激素剂量中位数4050 IU vs 3600 IU;两组卵丘-卵母细胞复合体、MII、受精卵母细胞、总囊胚、活检囊胚及整倍体囊胚的中位数无统计学显著差异。

关键数值与推荐

  • 匹配队列多变量回归:黄体期相对卵泡期的MII计数调整IRR为1.04(95%CI 1.00-1.09)。
  • 匹配队列多变量回归:黄体期相对卵泡期的囊胚计数调整IRR为1.05(95%CI 0.99-1.11)。
  • 匹配队列多变量回归:黄体期相对卵泡期的整倍体囊胚计数调整IRR为1.04(95%CI 0.94-1.14)。
  • 胚胎质量分布:卵泡期组(N=3831)顶级8.4%、良好49.5%、一般22.1%、差20.0%;黄体期组(N=2110)顶级9.4%、良好51.1%、一般20.9%、差18.6%。

临床怎么用

  • 作者认为黄体期刺激对整倍体胚胎数量和胚胎质量无不利影响。
  • 作者指出黄体期刺激的主要优势是启动卵巢刺激的时间窗口更宽,可能对时间受限的夫妇有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the impact of luteal-phase ovarian stimulation on embryo count, embryo ploidy, and embryo quality with that of follicular-phase stimulation. DESIGN: Retrospective cohort study between March 2017 and November 2024. SUBJECTS: Women who underwent ovarian stimulation, commenced either in the follicular or the luteal phase of the menstrual cycle. EXPOSURE: Luteal-phase ovarian stimulation MAIN OUTCOME MEASURES: Counts of euploid embryos and embryo quality. RESULTS: The initial cohort included 3,524 follicular-phase cycles and 552 luteal-phase cycles. After 2:1 propensity score matching on age, body mass index, antimüllerian hormone, antral follicle count, origin of semen, stimulation medication used, 1,058 follicular-phase cycles were matched to 550 luteal-phase cycles. Luteal-phase stimulations required a significantly longer duration (median 11.0 vs. 10 days) and higher total gonadotropin dose (median 4,050 IU vs. 3,300 IU). Median counts of cumulus-oocyte-complexes (COCs), mature (MII) and fertilized oocytes, total-, biopsied-, and euploid blastocysts did not differ significantly between groups before regression adjustment. Multivariable regression analyses on the matched cohort showed adjusted incidence rate ratios (IRRs) for MII count (luteal-phase vs. follicular-phase) of 1.04 (95% confidence interval [CI]: 1.00-1.09), for blastocyst count 1.05 (95% CI: 0.99-1.11), and for euploid blastocyst count 1.04 (95% CI: 0.94-1.14). Embryo quality distribution did not differ significantly between follicular-phase (N = 3,831: 8.4% top, 49.5% good, 22.1% fair, and 20.0% poor) and luteal-phase (N = 2,110: 9.4% top, 51.1% good, 20.9% fair, and 18.6% poor) groups. A total of 147 women with a luteal-phase and follicular-phase cycle within one year underwent a paired analysis. Again, luteal-phase cycles required significantly longer stimulation (median 11 vs. 10 days) and higher gonadotropin doses (median 4,050 IU vs. 3,600 IU). No statistically significant differences were found in the median number of COCs, MIIs, fertilized oocytes, total-, biopsied-, or euploid blastocysts between the paired luteal-phase and follicular-phase cycles for these women. CONCLUSION: Ovarian stimulation initiated in the luteal phase has no detrimental impact on ploidy number or embryo quality. The key advantage of luteal-phase stimulation is an extended duration for initiating ovarian stimulation, which can be useful for couples with time constraints.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Lawrenz B, Peralta S, Kalafat E, et al. Similar outcomes, different timings: luteal vs. follicular stimulation in in vitro fertilization. Fertil Steril. 2025. PMID: 40907649. doi:10.1016/j.fertnstert.2025.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。